0002092967
Company

Fort Technology Inc

Agricultural Chemicals · FRTT

ipo amended DRS/A

Filing Timeline

SEC EDGAR
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
Fort Technology Inc. is an e-commerce consumer products goods (CPG) company focused on pest control products via Amazon's FBA and FBM models. The company acquired Fort UK in July 2025, leading to a name change from Impact Acquisitions Corp. The current filing reflects updates to its capital structure, including a reverse stock split, and details its emergence as a controlled company under Nasdaq rules. The filing emphasizes its expansion into European markets and plans for U.S. entry, with financial reporting under IFRS.
2026-02-06 · 0001213900-26-013015
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
Fort Technology Inc. is an e-commerce consumer goods company focused on pest control products via Amazon, utilizing FBA and FBM models. The company completed an acquisition of Fort UK in July 2025, leading to a name change from Impact Acquisitions Corp. to Fort Technology Inc. The filing reflects updated share structure, including a reverse split, and plans to expand to the U.S. market. The company is a controlled company under Nasdaq rules and an emerging growth company with exemptions from certain reporting requirements.
2026-01-12 · 0001213900-26-003285
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
Fort Technology Inc. is an e-commerce consumer products goods (CPG) company focused on assembling and selling pest control products via Amazon's Marketplace using FBA and FBM models. The company acquired Fort Products Limited in July 2025, transitioning from Impact Acquisitions Corp. to its current name. It operates in the U.K., Germany, France, the Netherlands, Spain, Italy, and Poland, with plans to expand to the U.S. (pending regulatory approvals). The filing reflects its emergence as a growth company under the JOBS Act, with financial reporting under IFRS and a reverse stock split effective October 2025.
2025-10-22 · 0001213900-25-101243
Comparable Deals

2 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 2 using nearest neighbors.
-14.2%
Median day-1
0%
Above issue
-20.3%
Median week-1
-20.9%
Downside (p10)

Recent News

No recent news stored for this issuer.